Aegon Completes Sale of Unirobe Meeùs Groep
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Allergen (AGN) PT Lowered to $221 at RBC Capital; Reiterates Outperform
November 2, 2017 8:39 AM EDTRBC Capital lowered its price target on Allergen (NYSE: AGN) to $221.00 (from $250.00) while maintaining a Outperform rating following the company's 3Q earnings report.
Analyst Randall Stanicky still sees unlocked value and expect shareholder pressure to increase and add share support especially if that... More
Allergan (AGN) Should Be Up - Evercore ISI's Raffat
November 1, 2017 10:34 AM EDTEvercore ISI analyst Umer Raffat argues that Allergan (NYSE: AGN) stock should be up and thinks the call went well.
Raffat notes management was very clear about expectations into next year. They also provided clarity on milestone payments etc. over next few years.
From his perspective, the 3 most important things on the call... More
